Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-12-30 00:38 |
6K: results of the Annual General Meeting of Shareholders of the Company held o…
|
English | 124.6 KB | ||
| 2021-12-30 00:38 |
6K: results of the Annual General Meeting of Shareholders of the Company held o…
|
English | 36.6 KB | ||
| 2021-12-23 11:13 |
Adjournment of annual general meeting- will be reconvened on, December 29, 2021
|
English | 71.2 KB | ||
| 2021-12-23 11:13 |
Adjournment of annual general meeting- will be reconvened on, December 29, 2021
|
English | 281.7 KB | ||
| 2021-12-23 11:13 |
Adjournment of annual general meeting- will be reconvened on, December 29, 2021
|
English | 163.9 KB | ||
| 2021-12-23 00:18 |
Adjournment of annual general meeting- will be reconvened on, December 29, 2021
|
English | 124.5 KB | ||
| 2021-12-23 00:18 |
Adjournment of annual general meeting- will be reconvened on, December 29, 2021
|
English | 36.9 KB | ||
| 2021-12-09 15:40 |
Purple Biotech Appoints Senior Business
Development Executive Fabien Sebille as…
|
English | 142.1 KB | ||
| 2021-12-09 15:40 |
Purple Biotech Appoints Senior Business
Development Executive Fabien Sebille as…
|
English | 36.3 KB | ||
| 2021-12-06 15:40 |
6K: Purple Biotech Announces Initiation of Part 2 of Ongoing Phase 1/2 Clinical…
|
English | 156.0 KB | ||
| 2021-12-06 15:40 |
6K: Purple Biotech Announces Initiation of Part 2 of Ongoing Phase 1/2 Clinical…
|
English | 36.5 KB | ||
| 2021-11-17 01:43 |
6K:Company Presentation
|
English | 3.4 MB | ||
| 2021-11-17 01:43 |
6K:Company Presentation
|
English | 36.2 KB | ||
| 2021-11-11 00:55 |
Immediate Report of Meeting to be held on December 22,2021,proxy
|
English | 71.2 KB | ||
| 2021-11-11 00:55 |
Immediate Report of Meeting to be held on December 22,2021,proxy
|
English | 281.7 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
